ArticleCancer immunology research2019

Enhanced SLAMF7 Homotypic Interactions by Elotuzumab Improves NK Cell Killing of Multiple Myeloma.

Tatiana Pazina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.